ai3Bio launches from stealth, Matchpoint's big raise for new autoimmune drug, layoffs at Foghorn and Enanta
Plus another Eli Lilly acquisition moves to Arsenal Yards
Neumora's Phase 3 Trial Miss and a Trio of VC Raises
Watertown companies have now raised $245 million in VC funds in 2026
Another Watertown Biotech Goes Public and the Commonwealth Claws Back Hiring Tax Credits
Plus pre-clinical data results and more!
Kestrel's $1.45 billion AbbVie Deal, FDA Approves First Ever PROTAC, and Werewolf Breaks Arsenal Lease.
Plus more details on Windgap's big pharma partnership and a number of people moves.
Watertown Journal Club - Posterpalooza
Two big conferences last month generated a flurry of posters from Watertown biotechs
All About Watertown's VC Funding
2025 Funding numbers are in, 2026 early raises, Lyra Therapeutics runs out of time and more
What we're looking forward to in 2026
Neumora's positive clinical data , new tenants at the Arsenal, and more
Kymera and Psithera's Funding Haul
A Multi-Million dollar public offering, the developing race for a dupilumab alternative, business awards, and more.